Picard Medical, Inc. (NYSE American: PMI), parent company of SynCardia Systems LLC, announced that it is not aware of any undisclosed material change in its operations or financial condition that would account for the recent volatility in its stock price.
The Company remains focused on executing its strategic and operational priorities and will continue to comply with all disclosure obligations under applicable securities laws.
Picard Medical, Inc. is the parent company of SynCardia Systems LLC, maker of the world's first U.S. and Canadian commercially-approved total artificial heart.
About Picard Medical and SynCardia.
Author summary: Picard Medical addresses stock price volatility.